HAEMALOGIX

HaemaLogiX is researching immune based treatments (Monoclonal Antibodies, CAR T cell therapies and Bispecific antibodies) that target unique antigens on malignant cells to treat patients suffering from blood cancers (Multiple Myeloma) and other life-threatening diseases (AL Amyloidosis)... The HaemaLogiX team is researching immune-based treatments that target unique antigens on malignant cells to improve the quality of life of patients suffering from blood cancers... Following the discovery of two unique antigens on malignant Bone Marrow Cells, we are developing Monoclonal Antibodies, CAR T cell Therapies and Bispecific Antibodies that specifically target those malignant cells.

Also known as: HaemaLogiX Ltd.

Primary location: Australia